Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C

World Journal of Gastroenterology

Volumn 15, Issue 40, 2009, Pages 5010-5013

  Sibulesky, Lena ^a   Nguyen, Justin H ^a   Paz Fumagalli, Ricardo ^a   Taner, C Burcin ^a   Dickson, Rolland C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Hypersplenism; Leukopenia; Liver transplant; Recurrent hepatitis C; Thrombocytopenia

Indexed keywords

ARTIFICIAL EMBOLISM; GRAFT RECIPIENT; HEPATITIS C; HUMAN; HYPERSPLENISM; LIVER GRAFT; PORTAL HYPERTENSION; POSTOPERATIVE HEMORRHAGE; RECURRENT DISEASE; REVIEW; SEPSIS; SPLEEN ARTERY; SPLENECTOMY; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT RESPONSE; VARICOSIS; VEIN THROMBOSIS;

EID: 73449122253     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.5010     Document Type: Review

References (31)

1. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889-896
2. Gane E. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transpl 2003; 9: S28-S34
3. Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999; 29: 250-256
4. Gordon FD, Kwo P, Vargas HE. Treatment of hepatitis C in liver transplant recipients. Liver Transpl 2009; 15: 126-135
5. Chang JH, Choi JY, Woo HY, Kwon JH, You CR, Bae SH, Yoon SK, Choi MG, Chung IS, Kim DG. Severe thrombocytopenia before liver transplantation is associated with delayed recovery of thrombocytopenia regardless of donor type. World J Gastroenterol 2008; 14: 5723-5729
6. Megison SM, McMullin ND, Andrews WS. Selective use of splenectomy after liver transplantation in children. J Pediatr Surg 1990; 25: 881-884
7. Jeng LB, Lee CC, Chiang HC, Chen TH, Hsu CH, Cheng HT, Lai HC. Indication for splenectomy in the era of living-donor liver transplantation. Transplant Proc 2008; 40: 2531-2533
8. Kato H, Usui M, Azumi Y, Ohsawa I, Kishiwada M, Sakurai H, Tabata M, Isaji S. Successful laparoscopic splenectomy after living-donor liver transplantation for thrombocytopenia caused by antiviral therapy. World J Gastroenterol 2008; 14: 4245-4248
9. Kishi Y, Sugawara Y, Akamatsu N, Kaneko J, Tamura S, Kokudo N, Makuuchi M. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin Transplant 2005; 19: 769-772
10. Tashiro H, Itamoto T, Ohdan H, Fudaba Y, Kohashi T, Amano H, Ishiyama K, Takahashi S, Aikata H, Chayama K, Arihiro K, Asahara T. Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation? J Gastroenterol Hepatol 2007; 22: 959-960
11. Settmacher U, Nüssler NC, Glanemann M, Haase R, Heise M, Bechstein WO, Neuhaus P. Venous complications after orthotopic liver transplantation. Clin Transplant 2000; 14: 235-241
12. Troisi R, Hesse UJ, Decruyenaere J, Morelli MC, Palazzo U, Pattyn P, Colardyn F, Maene L, de Hemptinne B. Functional, life-threatening disorders and splenectomy following liver transplantation. Clin Transplant 1999; 13: 380-388
13. Samimi F, Irish WD, Eghtesad B, Demetris AJ, Starzl TE, Fung JJ. Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci 1998; 43: 1931-1937
14. Neumann UP, Langrehr JM, Kaisers U, Lang M, Schmitz V, Neuhaus P. Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation. Transpl Int 2002; 15: 226-232
15. Recommended adult immunization schedule: United States, 2009*. Ann Intern Med 2009; 150: 40-44
16. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004; 4 Suppl 10: 160-163
17. Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect 2001; 7: 657-660
18. Kumar D, Chen MH, Wong G, Cobos I, Welsh B, Siegal D, Humar A. A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients. Clin Infect Dis 2008; 47: 885-892
19. Evans DI. Postsplenectomy sepsis 10 years or more after operation. J Clin Pathol 1985; 38: 309-311
20. Maddison FE. Embolic therapy for hypersplenism (Abstract). Invest Radiol 1973; 8: 280-281
21. Mozes MF, Spigos DG, Pollak R, Abejo R, Pavel DG, Tan WS, Jonasson O. Partial splenic embolization, an alternative to splenectomy - results of a prospective, randomized study. Surgery 1984; 96: 694-702
22. Hayashi H, Beppu T, Masuda T, Mizumoto T, Takahashi M, Ishiko T, Takamori H, Kanemitsu K, Hirota M, Baba H. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol 2007; 22: 1638-1642
23. Bárcena R, Gil-Grande L, Moreno J, Foruny JR, Otón E, García M, Blázquez J, Sánchez J, Moreno A, Moreno A. Partial splenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin. Transplantation 2005; 79: 1634-1635
24. Chao CP, Nguyen JH, Paz-Fumagalli R, Dougherty MK, Stockland AH. Splenic embolization in liver transplant recipients: early outcomes. Transplant Proc 2007; 39: 3194-3198
25. Sohara N, Takagi H, Kakizaki S, Sato K, Mori M. The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia. Transpl Int 2006; 19: 255-257
26. Sakai T, Shiraki K, Inoue H, Sugimoto K, Ohmori S, Murata K, Takase K, Nakano T. Complications of partial splenic embolization in cirrhotic patients. Dig Dis Sci 2002; 47: 388-391
27. Zhu K, Meng X, Qian J, Huang M, Li Z, Guan S, Jiang Z, Shan H. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis 2009; 41: 411-416
28. Burra P. Hepatitis C. Semin Liver Dis 2009; 29: 53-65
29. Kuter DJ. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med 2009; 60: 193-206
30. McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, Bourliere M, Berg T, Gordon SC, Campbell FM, Theodore D, Blackman N, Jenkins J, Afdhal NH. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med 2007; 357: 2227-2236
31. Panzer S. Eltrombopag in chronic idiopathic thrombocytopenic purpura and HCV-related thrombocytopenia. Drugs Today (Barc) 2009; 45: 93-99